Laura Devillier

B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor–transduced T cells

James N. Kochenderfer, Mark E. Dudley, Steven A. Feldman et al. · Blood · 2011 · 1.4K citations · Full text

Tumor-specific CD4+ Melanoma Tumor-infiltrating Lymphocytes

Kevin M. Friedman, Peter A. Prieto, Laura Devillier et al. · Journal of Immunotherapy · 2012 · 102 citations · Full text

Specific Reactivity, Cell Therapy, Immunology +19

Clinical scale rapid expansion of lymphocytes for adoptive cell transfer therapy in the WAVE® bioreactor

Robert Somerville, Laura Devillier, Maria R. Parkhurst et al. · Journal of Translational Medicine · 2012 · 90 citations · Full text

Augmented Lymphocyte Expansion from Solid Tumors With Engineered Cells for Costimulatory Enhancement

Kevin M. Friedman, Laura Devillier, Steven A. Feldman et al. · Journal of Immunotherapy · 2011 · 21 citations · Full text

Cell Therapy, Til Generation, Immunology +21

Dramatic Regression of Chronic Lymphocytic Leukemia in the First Patient Treated With Donor-Derived Genetically-Engineered Anti-CD19-Chimeric-Antigen-Receptor-Expressing T Cells After Allogeneic Hematopoietic Stem Cell Transplantation

James N. Kochenderfer, Mark E. Dudley, I. Maric et al. · Biology of Blood and Marrow Transplantation · 2011 · 10 citations · Full text

Cell Therapy, Transplantation, Marrow Transplantation +14